SuperworthIQVIA profit margin IQV
Gross, operating and net profit as a share of revenue over the last twelve months, from 2012.
- Net margin, 12 months
- 8.1%
- Operating margin, 12 months
- 13.0%
- Net margin on a year earlier
- +0.2 pts
- Peer median
- 16.8%
Over the twelve months to Jun 30, 2026, IQVIA kept 8.1% of its revenue as net profit, with an operating margin of 13.0% and a gross margin of 33.0%.
Five years earlier its net margin was 4.7%.
The median for 10 diagnostics and research stocks of a similar size is 16.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 8.3% | 13.4% | 33.3% |
| FY2024 | 8.9% | 14.3% | 34.9% |
| FY2023 | 9.1% | 13.2% | 35.0% |
| FY2022 | 7.6% | 12.5% | 34.9% |
| FY2021 | 7.0% | 10.0% | 33.5% |
| FY2020 | 2.5% | 6.4% | 34.0% |
| FY2019 | 1.7% | 7.0% | 34.2% |
| FY2018 | 2.5% | 7.1% | 35.2% |
| FY2017 | 13.2% | 6.9% | 35.1% |
| FY2016 | 1.7% | 9.3% | 53.0% |
| FY2015 | 6.7% | 11.3% | 52.8% |
| FY2014 | 6.5% | 10.8% | 50.8% |
| FY2013 | 4.4% | 9.1% | 51.5% |
| FY2012 | 3.6% | 8.1% | 43.9% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 8.1% | +0.2 pts | 13.0% | |
| Q1 FY26 | 8.3% | −0.3 pts | 13.2% | |
| Q4 FY25 | 8.3% | −0.6 pts | 13.4% | |
| Q3 FY25 | 8.1% | −1.1 pts | 13.7% | |
| Q2 FY25 | 7.9% | −1.5 pts | 13.9% | |
| Q1 FY25 | 8.6% | −0.4 pts | 14.1% | |
| Q4 FY24 | 8.9% | −0.2 pts | 14.3% | |
| Q3 FY24 | 9.2% | +1.7 pts | 13.6% | |
| Q2 FY24 | 9.4% | +1.9 pts | 13.2% | |
| Q1 FY24 | 9.0% | +1.7 pts | 13.4% | |
| Q4 FY23 | 9.1% | +1.5 pts | 13.2% | |
| Q3 FY23 | 7.5% | −0.7 pts | 12.5% |
Against its peers
Companies in Medical - Diagnostics & Research nearest IQVIA's size, closest first, today.
| Company | Profit margin |
|---|---|
| IQVIQVIA | 8.1% |
| WATWaters | 3.6% |
| IDXXIDEXX Laboratories | 25.0% |
| AAgilent Technologies | 19.5% |
| ILMNIllumina | 18.4% |
| MTDMettler-Toledo International | 21.9% |
| DGXQuest Diagnostics | 9.2% |
| LHLabcorp | 7.0% |
| MEDPMedpace | 17.7% |
| RVTYRevvity | 8.2% |
| DHRDanaher | 15.9% |
| Peer median | 16.8% |
Where IQVIA ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on IQVIA
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.